• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿拉伯联合酋长国迪拜,出现了高产黏菌素耐药的同时产 OXA-48 型和 NDM 碳青霉烯酶的肺炎克雷伯菌 ST14 克隆株。

Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.

机构信息

Microbiology laboratory, School of Pharmacy, Saint-Joseph University, Beirut, Lebanon; College of Natural and Health Sciences, Zayed University, Dubai, United Arab Emirates.

Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

出版信息

Int J Antimicrob Agents. 2018 Jul;52(1):90-95. doi: 10.1016/j.ijantimicag.2018.03.003. Epub 2018 Mar 9.

DOI:10.1016/j.ijantimicag.2018.03.003
PMID:29530587
Abstract

Few studies have addressed the molecular epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) isolates in the Arabian Peninsula, and such investigations have been missing from Dubai, a major economical, tourism and medical centre of the region. The antibiotic susceptibility, the carbapenemase type produced, and the clonality of 89 CRE strains isolated in five major Dubai hospitals in June 2015 to June 2016 were determined. Thirty-three percent of the collection of 70 Klebsiella pneumoniae, 13 Escherichia coli and 6 other Enterobacteriaceae were extremely drug resistant, 27% were resistant to colistin, and 4.5% (4 K. pneumoniae isolates) were resistant to all antibiotics tested. The colistin resistance rate in K. pneumoniae was 31.4%. None of the isolates carried mobile colistin resistance genes. Seventy-seven isolates produced carbapenemase: 53.3% OXA-48-like, 24.7% NDM and 22.1% both OXA-48-like and NDM, respectively. Pulsed-field gel electrophoresis clustered 50% of K. pneumoniae into a 35-membered group, which showed significant association with double carbapenemase production, with extreme drug resistance, and with being isolated from Emirati patients. Members of the cluster belonged to sequence type ST14. The rate of colistin resistance in K. pneumoniae ST14 was 37.1% vs. 27.1% of K. pneumoniae isolates outside of the cluster. Two of the panresistant K. pneumoniae isolates also belonged to ST14, whereas the other two were ST15 and ST231, respectively. In conclusion, beyond the overall high colistin resistance rate in CRE, the emergence of a highly resistant clone of K. pneumoniae ST14 in all Dubai hospitals investigated is a serious problem requiring immediate attention.

摘要

在阿拉伯半岛,很少有研究涉及碳青霉烯类耐药肠杆菌科(CRE)分离株的分子流行病学,而在该地区的主要经济、旅游和医疗中心迪拜,也缺乏此类研究。本研究旨在确定 2015 年 6 月至 2016 年 6 月期间在迪拜五家主要医院分离的 89 株 CRE 菌株的抗生素敏感性、产生的碳青霉烯酶类型和克隆性。在所收集的 70 株肺炎克雷伯菌、13 株大肠埃希菌和 6 株其他肠杆菌科细菌中,33%为极度耐药,27%对黏菌素耐药,4.5%(4 株肺炎克雷伯菌)对所有测试的抗生素均耐药。肺炎克雷伯菌的黏菌素耐药率为 31.4%。分离株均未携带移动性黏菌素耐药基因。77 株产碳青霉烯酶:53.3%为 OXA-48 样,24.7%为 NDM,22.1%为 OXA-48 样和 NDM 均产。脉冲场凝胶电泳将 50%的肺炎克雷伯菌聚类成一个 35 株组成的群,该群与双重碳青霉烯酶产生、极度耐药以及从阿联酋患者中分离有关。该群的成员属于序列型 ST14。群内肺炎克雷伯菌 ST14 的黏菌素耐药率为 37.1%,群外肺炎克雷伯菌的耐药率为 27.1%。两株泛耐药肺炎克雷伯菌也属于 ST14,而另外两株分别属于 ST15 和 ST231。总之,除了 CRE 中总体较高的黏菌素耐药率之外,在所有调查的迪拜医院中,均出现了高度耐药的肺炎克雷伯菌 ST14 克隆,这是一个亟待关注的严重问题。

相似文献

1
Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.在阿拉伯联合酋长国迪拜,出现了高产黏菌素耐药的同时产 OXA-48 型和 NDM 碳青霉烯酶的肺炎克雷伯菌 ST14 克隆株。
Int J Antimicrob Agents. 2018 Jul;52(1):90-95. doi: 10.1016/j.ijantimicag.2018.03.003. Epub 2018 Mar 9.
2
National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.2014年法国产碳青霉烯酶肠杆菌科细菌对黏菌素耐药情况的全国性调查以及由产OXA-48型黏菌素耐药肺炎克雷伯菌引起的暴发
Euro Surveill. 2016 Sep 15;21(37). doi: 10.2807/1560-7917.ES.2016.21.37.30339.
3
Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).意大利瓦莱达奥斯塔地区耐碳青霉烯类肠杆菌科的分子流行病学研究显示,产 KPC-2 的肺炎克雷伯菌克隆复合体 101(ST101 和 ST1789)的出现。
BMC Microbiol. 2015 Nov 9;15(1):260. doi: 10.1186/s12866-015-0597-z.
4
Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.突尼斯出现耐多粘菌素碳青霉烯酶肠杆菌科肺炎克雷伯菌疫情。
J Glob Antimicrob Resist. 2017 Sep;10:88-94. doi: 10.1016/j.jgar.2017.03.017. Epub 2017 Jul 12.
5
Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.韩国五家医院产碳青霉烯酶肠杆菌科细菌的流行情况及分子特征
Ann Lab Med. 2016 Nov;36(6):529-35. doi: 10.3343/alm.2016.36.6.529.
6
Genetic support of carbapenemases in double carbapenemase producer Klebsiella pneumoniae isolated in the Arabian Peninsula.阿拉伯半岛分离出的产双碳青霉烯酶肺炎克雷伯菌中碳青霉烯酶的基因支持
Acta Microbiol Immunol Hung. 2018 Jun 1;65(2):135-150. doi: 10.1556/030.65.2018.005. Epub 2018 Feb 23.
7
OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity.肺炎克雷伯菌 ST14、ST15、ST23、ST48 和 ST231 中的 OXA-181 类碳青霉烯酶:与 NDM-5、耐药组、传播性和基因组多样性共存于败血症新生儿中。
mSphere. 2021 Jan 13;6(1):e01156-20. doi: 10.1128/mSphere.01156-20.
8
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla and bla .肠杆菌科碳青霉烯类耐药菌在两所伊朗大学医院住院患者中的携带情况的分子特征:同时产生 bla 和 bla 的首次报告
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2127-2135. doi: 10.1007/s10096-017-3035-3. Epub 2017 Jun 21.
9
Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.以色列碳青霉烯类和黏菌素耐药肺炎克雷伯菌ST512临床分离株的传播:需警惕的原因
Microb Drug Resist. 2019 Jan/Feb;25(1):63-71. doi: 10.1089/mdr.2018.0014. Epub 2018 Aug 21.
10
Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an IS-Directed Insertion in the Gene in the United Arab Emirates.泛耐药肺炎克雷伯菌序列型147在阿联酋多家医院的出现及基因中存在插入序列介导的插入情况
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00418-17. Print 2017 Jul.

引用本文的文献

1
The magnitude of MDR carbapenemase-producing Enterobacteriaceae isolates and associated factors among hospitalized patients of Northeast Ethiopia.埃塞俄比亚东北部住院患者中产多重耐药碳青霉烯酶肠杆菌科细菌分离株的数量及相关因素
JAC Antimicrob Resist. 2025 May 22;7(3):dlaf080. doi: 10.1093/jacamr/dlaf080. eCollection 2025 Jun.
2
Efficacy of colistin-based combinations against pandrug-resistant whole-genome-sequenced Klebsiella pneumoniae isolated from hospitalized patients in Egypt: an in vitro/vivo comparative study.基于黏菌素的联合用药方案对从埃及住院患者中分离出的全基因组测序泛耐药肺炎克雷伯菌的疗效:一项体外/体内比较研究
Gut Pathog. 2024 Dec 3;16(1):73. doi: 10.1186/s13099-024-00667-z.
3
Global prevalence of mutation in the gene among clinical isolates of colistin-resistant : a systematic review and meta-analysis.
耐黏菌素临床分离株中该基因的全球突变流行率:一项系统评价和荟萃分析。
Front Microbiol. 2024 Jun 7;15:1386478. doi: 10.3389/fmicb.2024.1386478. eCollection 2024.
4
The emergence of highly resistant and hypervirulent Klebsiella pneumoniae CC14 clone in a tertiary hospital over 8 years.8 年来,三级医院中高度耐药和高毒力肺炎克雷伯菌 CC14 克隆的出现。
Genome Med. 2024 Apr 18;16(1):58. doi: 10.1186/s13073-024-01332-5.
5
First Report of Colistin-Resistant Carrying IncI2(delta) and IncX4 Plasmids from Camels () in the Gulf Region.来自海湾地区骆驼的携带IncI2(δ)和IncX4质粒的耐黏菌素菌株的首次报告。
Antibiotics (Basel). 2024 Feb 28;13(3):227. doi: 10.3390/antibiotics13030227.
6
Outbreak of colistin and carbapenem-resistant Klebsiella pneumoniae ST16 co-producing NDM-1 and OXA-48 isolates in an Iranian hospital.伊朗一家医院中出现同时产 NDM-1 和 OXA-48 的耐碳青霉烯类肺炎克雷伯菌 ST16 爆发流行
BMC Microbiol. 2024 Feb 17;24(1):59. doi: 10.1186/s12866-024-03207-6.
7
In Vitro Antimicrobial Activity of Five Newly Approved Antibiotics against Carbapenemase-Producing Enterobacteria-A Pilot Study in Bulgaria.五种新批准抗生素对产碳青霉烯酶肠杆菌的体外抗菌活性——保加利亚的一项初步研究
Antibiotics (Basel). 2024 Jan 15;13(1):81. doi: 10.3390/antibiotics13010081.
8
Epidemiology and antimicrobial resistance trends of species in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.阿联酋种的流行病学和抗菌药物耐药趋势:对 12 年国家抗菌药物耐药监测数据的回顾性分析。
Front Public Health. 2024 Jan 4;11:1245131. doi: 10.3389/fpubh.2023.1245131. eCollection 2023.
9
Resistance to aminoglycoside and quinolone drugs among clinical isolates from northern Jordan.约旦北部临床分离株对氨基糖苷类和喹诺酮类药物的耐药性
Heliyon. 2023 Dec 6;10(1):e23368. doi: 10.1016/j.heliyon.2023.e23368. eCollection 2024 Jan 15.
10
A Review of Resistance to Polymyxins and Evolving Mobile Colistin Resistance Gene () among Pathogens of Clinical Significance.临床重要病原菌对多粘菌素的耐药性及不断演变的可移动黏菌素耐药基因()综述
Antibiotics (Basel). 2023 Nov 6;12(11):1597. doi: 10.3390/antibiotics12111597.